Jeff Schaal Ph.D

Director, Research

Jeff is an expert in recombinant engineering of peptide/protein sequences, nanoparticle design for drug delivery systems, creating and extensive testing animal models of cancer, and developing next-generation radionuclide therapeutics for overcoming tumor resistance to conventional radio chemotherapy.  He completed his Ph.D. in Biomedical Engineering from Duke University under the mentor-ship of Ashutosh Chilkoti where he developed a thermally-responsive biopolymer system for the delivery of radionuclide brachytherapy in prostate and pancreatic cancer. He was awarded a NIH T32 fellowship in the pursuit of his multi-disciplinary research in tissue, cellular, and protein engineering. Additionally at Duke, he managed a project developing novel nanoparticle chemotherapeutics in collaboration with Dr. Reddy’s Laboratories, Inc. Prior to graduate school, Jeff received a B.S. in Chemical Engineering from the University of Notre Dame. He also worked at Deloitte Consulting, LLC specializing in full life-cycle project management and enterprise system development.